Today’s biotech news, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Saturday, July 11, 2026
Get the News Brief in your inbox
Every morning, free — the day’s top biotech signals.
The Nasdaq Composite Index ( COMP:IND ) ended the final day of the week flat but in the green. It closed +0.29% on Friday. Earlier in the day, Nasdaq triggered its first bullish MACD crossover in six weeks, according to Bluekurtic Market Insights. The Moving
VERAXA Biotech ( VRXA ) appointed Carl von Halem as interim chief financial officer, succeeding Torsten Bürgermeister Carl von Halem currently serves as CFO of Xlife Sciences and played a key role in VERAXA’s public listing. More on Veraxa Biotech AG Veraxa Bi…
alexsl Morgan Stanley on Friday resumed its coverage of Lakefront Biotherapeutics ( LKFT ), a biotech formerly known as Galapagos, with an Equal Weight rating and $30 target, citing its Ouro Medicines buyout in June. The $1.7B deal, partly funded by Gilead (
Images By Tang Ming Tung During the second quarter, the ClearBridge International Growth EAFE Strategy outperformed its MSCI EAFE Index benchmark. On an absolute basis, the strategy produced positive gains across seven of the 10 sectors in which it was investe…
Michael Vi/iStock Editorial via Getty Images Shares of Ionis Pharmaceuticals ( IONS ) continued to trade lower on Friday after Roche ( RHHBY ) ( RHHBF ) said it is discontinuing clinical studies for two experimental therapies developed with the U.S. drugmaker…
This week's dividend activity included increased payouts from PNC Financial ( PNC ) and CF Industries ( CF ) as well as declarations from Costco ( COST ) and Phillips 66 ( PSX ). Additionally, looking towards next week, industry players such as Abbott Labs ( A…
Silo Pharma ( SILO ) entered definitive agreements for a private placement expected to raise ~$4M in gross proceeds. The company will issue 619,965 common shares (or pre-funded warrants) along with Series A-3 and Series A-4 warrants. The securities are priced…
Cue Biopharma ( CUE ) has entered into a definitive securities purchase agreement to raise approximately $50.0M in gross proceeds through a private placement with a group of accredited institutional investors. The financing includes the issuance of 1.42M share…
Oselote/iStock via Getty Images Pfizer ( PFE ), Alnylam Pharma ( ALNY ), and BridgeBio Pharma ( BBIO ), which market drugs for a rare heart condition known as ATTR-CM, traded higher on Thursday after AstraZeneca ( AZN ) and Ionis Pharma ( ALNY
Alsu Faskhieva/iStock via Getty Images Shares of Forte Biosciences ( FBRX ) climbed on Thursday after the company posted early-stage trial results indicating that its lead asset, FB102, led to a statistically significant improvement in vitiligo symptoms as ear…